Grant: DANA-FARBER CANCER INSTITUTE, INC.
Primary Recipient
DANA-FARBER CANCER INSTITUTE, INC.
Amount
$2,228,805.00
Award Date
9/28/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
The goal of the proposed work is the development of novel approaches to the stimulation of fetal hemoglobin (HbF) production in red blood cells of adults. HbF is a known modifier of the severity of the major hemoglobin disorders, sickle cell anemia and be
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
DANA-FARBER CANCER INSTITUTE, INC. | Primary recipient | $1,581,895.00 |
MASSACHUSETTS GENERAL HOSPITAL, THE | Sub-recipient | $318,616.00 |
UNIVERSITY OF CALIFORNIA, LOS ANGELES | Sub-recipient | $226,410.00 |
CHILDREN'S HOSPITAL CORPORATION, THE | Sub-recipient | $101,884.00 |
Vendors Connected to Award
Vendor | Role | Amount |
---|---|---|
The Broad Institute, Inc. | Primary vendor | $52,025.00 |
Applied Biosystems | Primary vendor | $39,479.71 |
Stem Cell Technologies, Inc. | Primary vendor | $47,350.00 |
Qiagen | Primary vendor | $53,347.69 |